查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726219

蟲媒病毒檢測市場規模、佔有率、趨勢分析報告：按類型、最終用途、地區、細分市場預測，2025-2030 年

Arbovirus Testing Market Size, Share & Trends Analysis Report By Type (ELISA-Based Tests, RT-PCR Based Tests), By End-use (Diagnostic Laboratories, Hospitals, Research Centers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

蟲媒病毒檢測市場規模與趨勢

預計全球蟲媒病毒檢測市場到 2024 年將達到 11.2 億美元，2025 年至 2030 年的複合年成長率為 4.5%。

茲卡、登革熱和西尼羅河病毒等蟲媒病毒疾病發病率的上升推動了對強大檢測解決方案的需求。這些疾病在各個地區的盛行率不斷上升，增加了對準確診斷以有效管理疫情的需求。公眾和醫療保健系統意識的提高促進了監測活動的改善，從而能夠快速識別和應對潛在的疫情。

這是因為政府和醫療機構優先考慮及時檢測以遏制這些感染疾病的傳播。

蟲媒病毒檢測已成為防止被忽視的熱帶疾病（NTD）傳播的重要工具。根據世衛組織估計，大約五分之一的人口（約17億人）每年必須診斷和治療至少一種非傳染性疾病，主要發生在開發中國家和低收入國家。登革熱和基孔肯雅病 NTD 疫情影響了近 40% 的非洲地區。這些疾病在熱帶貧困地區和人跡罕至的地方更為普遍，因為這些地方條件惡劣，衛生條件差，有利於病毒的擴散。因此，大多數被忽視的熱帶疾病病例報告來自巴西、葉門、印度、孟加拉、中國以及中非和東非的幾個國家。因此，預計登革熱和基孔肯雅病發病率的上升將刺激對蟲媒病毒檢測的需求並推動市場成長。

此外，一些國際組織也開展了提高人們對被忽視的熱帶病認知的項目，包括美國全球健康舉措、美國疾病控制和預防中心的全球被忽視的熱帶病項目、世界衛生組織的全球被忽視的熱帶病項目以及美國美國國際開發署署的被忽視的熱帶病項目。這些項目主要致力於減少或消除登革熱和基孔肯雅病等被忽視的熱帶疾病。此外，世衛組織已於2023年10月啟動了針對被忽視的熱帶疾病（NTD）的世衛組織診斷專家審查小組（ERPD）的試驗計畫。該計畫的重點是提高醫護人員對NTD診斷工具的品管和可用性。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 蟲媒病毒檢測市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 蟲媒病毒檢測市場分析工具
    • 產業分析—波特五力分析
    • PESTLE分析

第4章 蟲媒病毒檢測市場類型、估價與趨勢分析

  • 類型細分儀表板
  • 蟲媒病毒檢測市場：類型變異分析
  • 2018-2030年全球蟲媒病毒檢測市場規模及趨勢分析（按類型）
  • 基於 ELISA 的檢測
  • 基於RT-PCR的檢測
  • 其他測試類型

第5章蟲媒病毒檢測市場：最終用途、估計與趨勢分析

  • 最終用途細分儀表板
  • 蟲媒病毒檢測市場：最終用途變異分析
  • 2018-2030年全球蟲媒病毒檢測市場規模及趨勢分析（依最終用途）
  • 診斷實驗室
  • 醫院
  • 研究中心
  • 其他

第6章 蟲媒病毒檢測市場：區域、估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 蟲媒病毒檢測市場（按地區）關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業熱圖分析
  • 公司簡介
    • Abbott
    • Thermo Fisher Scientific Inc.
    • NovaTec Immundiagnostica GmbH（Gold Standard Diagnostics Frankfurt GmbH）
    • Agilent Technologies, Inc.
    • EUROIMMUN Medical Laboratory Diagnostics AG
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-178-9

Arbovirus Testing Market Size & Trends:

The global arbovirus testing market size was valued at USD 1.12 billion in 2024 and is expected to grow at a CAGR of 4.5% from 2025 to 2030. The rising incidence of arboviral diseases such as Zika, dengue, and West Nile is fueling the demand for robust testing solutions. The increasing prevalence of these diseases in various regions has heightened the need for accurate diagnostics to manage outbreaks effectively. Increased awareness among the public and healthcare systems has led to improved surveillance efforts, enabling faster identification and response to potential outbreaks.

This greater focus on disease monitoring drives the arbovirus testing market, as governments and health organizations prioritize timely detection to control the spread of these infections.

Arbovirus testing has emerged as a pivotal tool in preventing the spread of these Neglected Tropical Diseases (NTDs). According to WHO estimates, around one-fifth of the population-about 1.7 billion people, mostly in developing and low-income nations-must receive diagnosis and treatment for at least one noncommunicable disease annually. The dengue and chikungunya NTD epidemic impacted almost 40% of Africa. These illnesses are more common in impoverished communities in tropical and hard-to-reach locations due to a favorable environment for virus growth and lack of hygiene. Thus, most NTD cases are reported from Brazil, Yemen, India, Bangladesh, China and several countries in Central and East Africa. Thus, the rising incidence of dengue and chikungunya is anticipated to fuel the demand for arbovirus testing, thereby driving market growth.

Moreover, several international organizations run programs to raise awareness of NTDs, including the United States Global Health Initiative, the Global NTD Program by the Centers for Disease Control and Prevention, the World Health Organization's Global NTD Programs, and the NTD Program by the United States Agency for International Development. These programs focus mainly on reducing or eliminating NTDs such as dengue and chikungunya. In addition, the WHO introduced a pilot program for a WHO Expert Review Panel for Diagnostic Products (ERPD) for NTDs in October 2023. This program focuses on enhancing the quality control and availability of NTD diagnostic tools for medical professionals.

Global Arbovirus Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global arbovirus testing market report on the basis of type, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • ELISA-based Tests
  • RT-PCR Based Tests
  • Other Test Types
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Diagnostic Laboratories
  • Hospitals
  • Research Centers
  • Other End Use
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. End Use Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Scenario

Chapter 3. Arbovirus Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Arbovirus Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Arbovirus Testing Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Arbovirus Testing Market: Type Movement Analysis
  • 4.3. Global Arbovirus Testing Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 4.4. ELISA-Based Tests
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. RT-PCR Based Tests
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Other Test Types
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Arbovirus Testing Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Arbovirus Testing Market: End Use Movement Analysis
  • 5.3. Global Arbovirus Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Hospitals
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Research Centers
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Other End Use
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Arbovirus Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Arbovirus Testing Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Germany
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. U.K.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.1.3. Competitive Scenario
      • 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.3.3. Competitive Scenario
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.4.3. Competitive Scenario
      • 6.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.5.3. Competitive Scenario
      • 6.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/ Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Thermo Fisher Scientific Inc.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. NovaTec Immundiagnostica GmbH (Gold Standard Diagnostics Frankfurt GmbH)
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Agilent Technologies, Inc.
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. EUROIMMUN Medical Laboratory Diagnostics AG
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Merck KGaA
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. F. Hoffmann-La Roche Ltd
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Siemens Healthineers AG
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. QIAGEN
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Bio-Rad Laboratories, Inc.
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Arbovirus Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 5. Global Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6. North America Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 7. North America Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 8. North America Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 10. U.S. Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. Canada Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13. Mexico Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 14. Mexico Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15. Europe Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 17. Europe Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 18. Germany Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 19. Germany Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20. U.K. Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 21. U.K. Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 22. France Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 23. France Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24. Italy Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 25. Italy Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 26. Spain Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 27. Spain Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 28. Denmark Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 29. Denmark Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. Sweden Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 31. Sweden Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 32. Norway Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 33. Norway Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37. Japan Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 38. Japan Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39. China Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 40. China Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41. India Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 42. India Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 43. South Korea Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 44. South Korea Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45. Australia Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 46. Australia Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47. Thailand Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 48. Thailand Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 49. Latin America Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 51. Latin America Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 52. Brazil Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 53. Brazil Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 55. Argentina Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Arbovirus Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 60. South Africa Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 64. UAE Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Arbovirus Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Arbovirus Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Arbovirus Testing Market: Market Outlook
  • Fig. 10 Arbovirus Testing Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Arbovirus Testing Market Driver Impact
  • Fig. 16 Arbovirus Testing Market Restraint Impact
  • Fig. 17 Arbovirus Testing Market Strategic Initiatives Analysis
  • Fig. 18 Arbovirus Testing Market: Type Movement Analysis
  • Fig. 19 Arbovirus Testing Market: Type Outlook and Key Takeaways
  • Fig. 20 ELISA-Based Tests Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 RT-PCR Based Tests Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Other Test Types Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 Arbovirus Testing Market: End Use Movement Analysis
  • Fig. 24 Arbovirus Testing Market: End Use Outlook and Key Takeaways
  • Fig. 25 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 26 Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 27 Research Centers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Other End Use Market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Arbovirus Testing Market: Regional Movement Analysis
  • Fig. 30 Global Arbovirus Testing Market: Regional Outlook and Key Takeaways
  • Fig. 31 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 U.K. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Kuwait Market Estimates and Forecasts, 2018 - 2030